Characteristics of Moyamoya Syndrome in Pediatric Patients with Neurofibromatosis Type 1

Moyamoya syndrome (MMS) is a progressive cerebral arteriopathy with increased incidence in children with neurofibromatosis type 1 (NF1). Despite the potential for significant neurological morbidity including stroke, little is known about the natural history and no guidelines exist for screening and management of NF1-associated MMS.

Source: Pediatric Neurology - June 4, 2022 Category: Neurology Authors: Stephanie N. Brosius, Arastoo Vossough, Michael J. Fisher, Shih-Shan Lang, Lauren A. Beslow, Brandon J. George, Rebecca Ichord Tags: Research Paper Source Type: research